These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4073293)

  • 21. Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats.
    McAreavey D; Brown WB; Murray GD; Robertson JI
    J Hypertens; 1985 Jun; 3(3):275-9. PubMed ID: 3894516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension.
    Share L; Crofton JT; Ouchi Y
    Am J Med Sci; 1988 Apr; 295(4):314-9. PubMed ID: 3364463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vasopressin on cerebral blood flow in normotensive and DOC-salt hypertensive rats.
    Janczewski P; Szczepańska-Sadowska E
    Acta Physiol Pol; 1986; 37(1):47-50. PubMed ID: 3788608
    [No Abstract]   [Full Text] [Related]  

  • 25. Similar blood pressure but different outcome in rats with DOC and post-DOC hypertension.
    Reid R; Lindop G; Brown W; Lever AF; Lucie N; Webb D
    J Hypertens; 1983 Oct; 1(3):303-10. PubMed ID: 6681045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin in the rat with partial nephrectomy-salt hypertension.
    Lee-Kwon WJ; Share L; Crofton JT; Shade RE; Brooks B; Muirhead EE; Manning M; Sawyer WH
    Clin Exp Hypertens (1978); 1981; 3(2):281-97. PubMed ID: 7215069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
    Möhring J; Möhring B; Petri M; Haack D
    Am J Physiol; 1977 Mar; 232(3):F260-9. PubMed ID: 842673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidences against a primary role for the pituitary neural lobe in the development and maintenance of DOC-salt hypertension.
    Cannata MA; Taquini AC
    Acta Physiol Pharmacol Latinoam; 1987; 37(2):207-14. PubMed ID: 3425339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats.
    Dzielak DJ; Norman RA
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H945-9. PubMed ID: 4061671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of nitrendipine on blood pressure, plasma renin, and exchangeable sodium in DOC-salt hypertension in the rat.
    Otipka NA; Tonolo G; Brown WB; Robertson JI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S140-2. PubMed ID: 2455117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxycorticosterone hypertension in the intact weanling rat without salt loading.
    Rodriguez-Sargent C; Torres-Negron I; Cangiano JL; Martinez-Maldonado M
    Hypertension; 1990 Feb; 15(2 Suppl):I112-6. PubMed ID: 2298466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of vasopressin to hypertension.
    Share L; Crofton JT
    Hypertension; 1982; 4(5 Pt 2):III85-92. PubMed ID: 7049934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
    Oikawa R; Hosoda C; Nasa Y; Daicho T; Tanoue A; Tsujimoto G; Takagi N; Tanonaka K; Takeo S
    Cardiovasc Res; 2010 Jul; 87(1):187-94. PubMed ID: 20118201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure responses to enalapril in rats with one- and two-kidney DOC-NaCl hypertension.
    Arvola P; Nurmi AK; Säynävälammi P; Manninen V; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):67-71. PubMed ID: 2540388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.